Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Fort Lauderdale, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Alaunos Therapeutics, Inc. has filed 1,290 SEC EDGAR filings since 13 Feb 2001

SEC filing history

Showing 476-500 of 1,000 matching filings.

Per page
25
Current page
20
S-8 File 333-228291

S-8

Filing date
09 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
16 Oct 2018
Reporting date
10 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79364

SC 13D/A

Filing date
15 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
11 Oct 2018
Reporting date
05 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Oct 2018
Reporting date
05 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
09 Oct 2018
Reporting date
05 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
28 Sep 2018
Reporting date
28 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
24 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
20 Sep 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33038

DEFA14A

Filing date
04 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Aug 2018
Reporting date
31 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33038

DEFA14A

Filing date
31 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33038

DEFA14A

Filing date
29 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-33038

DEFA14A

Filing date
08 Aug 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-33038

DEF 14A

Filing date
08 Aug 2018
Reporting date
18 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

8-K

Filing date
08 Aug 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
31 Jul 2018
Reporting date
31 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33038

FORM 8-K

Filing date
27 Jul 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .